Error message

  • Deprecated function: Methods with the same name as their class will not be constructors in a future version of PHP; views_display has a deprecated constructor in require_once() (line 3139 of /services15/webpages/util/e/m/emedicine.site.aplus.net/emedicinelive.com/public/includes/bootstrap.inc).
  • Deprecated function: Methods with the same name as their class will not be constructors in a future version of PHP; views_many_to_one_helper has a deprecated constructor in require_once() (line 113 of /services15/webpages/util/e/m/emedicine.site.aplus.net/emedicinelive.com/public/sites/all/modules/ctools/ctools.module).

Omega-3 Fatty acids beneficial in Alzheimer\'s disease

Omega-3 fatty acids help to repair the brain damage.

Alzheimer’s disease is a progressive neurodegenerative disorder that represents the major cause of dementia in the world today. The Alzheimer’s is considered to be an incurable disease. The origin and discovery of the Alzheimer’s disease dates back to the year 1906 and it derives its name from its founder Alois Alzheimer, who was a German psychiatrist and neuro-pathologist. The initial symptoms of the Alzheimer’s disease include: impaired memory and confusion which is followed by increased irritability, impaired thought, marred speech, feeling of aggression, mood swings and eventually long term memory loss resulting in complete helplessness.Over 5 million people in the US currently suffer from this disease and that number is expected to quadruple by the year 2050, unless prevention efforts or disease modifying therapies are developed. The annual costs of care for patients with Alzheimer’ s disease severely tax the health care system today.

Fatty acids serve as both energy substrates and integral membrane component essential for proper neuronal and brain function. In the field of medical science, the past decade has seen the extensive use of Omega-2 fatty acids also known as 'brain food' in the management of Alzheimer’s disease. A recent review highlights the latest discoveries in the basic biology of omega-3 fatty acids in the brain in the animal model. The findings point out the benefits of omega-3 fatty acids and their relationship with the Alzheimer’s disease. Also, the review explores the results of clinical trial using Omega-3 fatty acids for the treatment of Alzheimer’s disease. Data results from the cross-sectional and prospective studies of the associations between dietary intakes of omega-3 PUFA (Polyunsaturated Fatty Acids) have been largely positive. These findings may further help in guiding the future use of omega-3 fatty acid supplementation in the management or prevention of early Alzheimer’s disease.

Reference:
Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease- A review by Gregory A Jicha and William R Markesbery conducted at University of Kentucky, Alzheimer’s Disease Center and the Sanders-Brown Center on Aging University of Kentucky College of Medicine, Lexington, USA. For more information, please visit: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854051/?tool=pubmed

Disclaimer: This article is written by a non-medical professional.

R